Global In Vitro Diagnostics (IVD) Market 2014 - 2020
- December, 2014
- Domain: Healthcare - Diagnostics
Pages:
Tables:
Charts:
Regions/Countries:
Companies:
Enquiry Hours:
- Get Free 10% Customization in this Report
In Vitro Diagnostics (IVD) is a technique wherein medical devices are made use of to examine specimens from different body fluids. These fluids help to detect disease conditions and infections via various tests conducted in laboratories and hospitals. The Global In Vitro Diagnostics (IVD) market is driven by increasing knowledge of rare diseases and improved application of personalized medicines. This In Vitro Diagnostics (IVD) market to get boosted by technological advancements to develop point-of-care (POC) hematology testing methods during the period 2014 - 2020.The reagents & kits market is expected have highest share of the Global In Vitro Diagnostics (IVD)market driven easy accessibility to a wide range of reagents.
North America is expected to consume the largest share of the In Vitro Diagnostics (IVD) market owing to acceptance of personalized medicine and organized health care system. The North America is followed by Europe, whose market is driven by its acceptance of technologically advanced products. The growth in the APAC region is driven by government investment in R&D activities. Some of the most prominent In Vitro Diagnostics (IVD) market players include Sysmex Corporation., Thermo Fisher Scientific Inc., Ortho-Clinical Diagnostics Inc. and others.
Infoholic Research’s Global In Vitro Diagnostics (IVD) market report provides detailed information about various market trends and applications covering different segments and regions. The major trends, drivers, restraints and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in IVDs.
This report also provides the competitive landscape of the leading players in Global In Vitro Diagnostics (IVD) market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific user requirement. The customization of the report is available based on countries, vendor profiles, enterprise, and vertical wise.
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 Pest Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
4 Market Outlook
4.1 Overview
4.2 Market Definition – Infoholic Research
4.3 Evolution
4.4 Market Trends
4.5 Importance of In vitro diagnostics (IVD)
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 Market Characteristics
5.1 In vitro diagnostics (IVD) Features
5.2 In vitro diagnostics (IVD) Advantages
5.3 In vitro diagnostics (IVD) Scope
5.4 Market Dynamics
5.4.1 Drivers
5.4.2 Opportunities
5.4.3 Restraints
5.4.4 DRO – Impact Analysis
5.4.5 Key Stakeholders
6 Product: Market Size and Analysis
6.1 Overview
6.2 Instruments
6.3 Reagents & kits
6.4 Others
7 Technology: Market Size and Analysis
7.1 Overview
7.2 Immunoassay
7.3 Clinical Chemistry
7.4 Others
8 Regions: Market Size and Analysis
8.1 Overview
8.2 Americas
8.3 EMEA
8.4 APAC
9 Market Attractiveness
9.1 Market Attractiveness by Product
9.2 Market Attractiveness by Technology
9.3 Market Attractiveness by Regions
10 Competitive Landscape
10.1 Overview
10.2 Vendor Assessment
11 Vendor Profiles
12 Companies to Watch For
13 Global Generalist
Annexure
Abbreviations
TABLE 1 GLOBAL IN-VITRO DIAGNOSTICS MARKET BY TYPES, 2016–2023 ($BILLION)
TABLE 2 GLOBALIN-VITRO DIAGNOSTICS MARKET BY APPLICATION, 2016–2023 ($BILLION)
TABLE 3 GLOBAL IN-VITRO DIAGNOSTICS MARKET BY TEST TYPES SEGMENTATION, 2016–2023 ($BILLION)
TABLE 4 GLOBAL IN-VITRO DIAGNOSTICS MARKET BY END-USER SEGMENTATION, 2016–2023 ($BILLION)
TABLE 5 GLOBAL IN-VITRO DIAGNOSTICS MARKET REVENUE BY REGIONS, 2016–2023 ($BILLION)
TABLE 6 IN-VITRO DIAGNOSTICS MARKET BY VENDOR RANKING, 2016
TABLE 7 OTHER PROMINENT VENDORS IN THE MARKET
TABLE 8 F. HOFFMANN-LA ROCHE: OFFERINGS
TABLE 9 F. HOFFMANN-LA ROCHE.: RECENT DEVELOPMENTS
TABLE 10 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
TABLE 11 ABBOTT LABORATORIES: RECENT DEVELOPMENTS
TABLE 12 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS
TABLE 13 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS
TABLE 14 DANAHER CORPORATION: OFFERINGS
TABLE 15 DANAHER CORPORATION: RECENT DEVELOPMENTS
TABLE 16 THERMOFISHER SCIENTIFIC: OFFERINGS
TABLE 17 THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS
TABLE 18 SYAMEX CORP: OFFERINGS
TABLE 19 SYSMEX CORP: RECENT DEVELOPMENTS
TABLE 20 BECTON DICKENSON AND COMPANY: RECENT DEVELOPMENTS
TABLE 21 ORTHO CLINICAL DIAGNOSTICS: RECENT DEVELOPMENTS
TABLE 22 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS
TABLE 23 ORTHO CLINICAL DIAGNOSTICS: RECENT DEVELOPMENTS
TABLE 24 BIOMERIEUS: RECENT DEVELOPMENTS
Research Framework
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
- Forecasting
Market related information is congregated from both primary and secondary sources.
Primary sources
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.
